UK neurotechnology needs funding and policy support to thrive

This title was summarized by AI from the post below.

The latest Centre for British Progress briefing makes an important point: if the UK wants to lead in neurotechnology, it must remove the barriers that hold back progress, from funding gaps to clinical adoption hurdles. Neurotechnology spans neuroscience, engineering, and clinical science. Progress depends on long-term vision, appropriate risk tolerance, and the ability to connect research with delivery. The report sets out clear priorities for the UK – from scaling today’s therapies through conditional commissioning and clinical fellowships, to enabling first-in-human studies via a dedicated MHRA route and establishing NHS neurotechnology hubs to accelerate translation. I'd also add that VC funding and patient capital need to flow more decisively into UK neurotechnology. The field remains underrepresented in the country’s investment landscape, yet it has the potential to reduce the staggering annual health and economic burden and shape the next major frontier in healthcare and human-technology integration. It is encouraging to see policymakers, researchers, and founders aligned on this challenge. Neurotechnology can transform how we understand and treat the brain, and the UK can be a global leader if we continue to empower the science, the talent, and the ambition needed to make it happen. This effort is already taking shape through major national programmes such as Advanced Research + Invention Agency (ARIA)’s £69M neurotechnology programme, which funds projects including three involving MintNeuro, and the Medical Research Council (MRC)’s £50M CoRE Centre, where we are proud to contribute alongside leading UK institutions. Thank you to Jamie Brannigan and Roa Powell for this excellent briefing at the Centre for British Progress. A thoughtful and timely analysis that highlights the growing strength of the UK’s neurotechnology ecosystem, and we appreciate MintNeuro being mentioned among the initiatives helping to drive it forward. 🔗 Read the full briefing here: https://lnkd.in/e7U_UbrsDorian #neurotechnology #braintech #UKinnovation #UKscience #UKengineering #ARIA #MRC #MHRA #NHS #InnovateUK #patientcapital #venturecapital

A crucial element often overlooked is the need for a robust public communication strategy. Public trust in brain-computer interfaces is fragile. Without proactive dialogue on ethics and data privacy, even the best-funded initiatives could face significant public resistance. Dorian Haci, PhD

To view or add a comment, sign in

Explore content categories